Pancreatic Cancer Cure Found, Drug Manufacturers Immediately Announce Early Retirement Plans
Industry Analysts Confirm Breakthrough Threatens Multi-Billion-Dollar Chronic Illness Market.
LONDON — Scientists have achieved what many in the healthcare industry considered unthinkable: a virus that effectively halts pancreatic cancer. Early trials of the Oncolytic Vax-3, administered to three patients, showed complete cessation of tumor growth and spread, triggering immediate panic among pharmaceutical executives whose entire business model relies on managing, not eliminating, terminal disease.
Comments
Post a Comment